GlobeNewswire Inc.··Nxera Pharma Co., Ltd.Nxera Pharma Pursues South Korea Insomnia Market With Daridorexant Filing
Nxera Pharma seeks South Korean approval for insomnia drug daridorexant, already marketed globally, with expected 2027 regulatory decision.
SGIOYPhase 3 trialregulatory approval